David Sim

7.4k total citations
43 papers, 1.4k citations indexed

About

David Sim is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Epidemiology. According to data from OpenAlex, David Sim has authored 43 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Cardiology and Cardiovascular Medicine, 6 papers in Pulmonary and Respiratory Medicine and 6 papers in Epidemiology. Recurrent topics in David Sim's work include Heart Failure Treatment and Management (28 papers), Cardiovascular Function and Risk Factors (15 papers) and Cardiac pacing and defibrillation studies (11 papers). David Sim is often cited by papers focused on Heart Failure Treatment and Management (28 papers), Cardiovascular Function and Risk Factors (15 papers) and Cardiac pacing and defibrillation studies (11 papers). David Sim collaborates with scholars based in Singapore, New Zealand and Netherlands. David Sim's co-authors include Fazlur Jaufeerally, Carolyn S.P. Lam, Lieng Hsi Ling, Mark Richards, Hean Yee Ong, Tze Pin Ng, Kui Toh Gerard Leong, Poh Shuan Daniel Yeo, Raymond Wong and Ping Chai and has published in prestigious journals such as Journal of the American College of Cardiology, European Heart Journal and Clinical Chemistry.

In The Last Decade

David Sim

40 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Sim Singapore 16 1.1k 243 187 151 137 43 1.4k
Fazlur Jaufeerally Singapore 17 1.0k 0.9× 221 0.9× 183 1.0× 147 1.0× 131 1.0× 40 1.4k
Patrícia Lourenço Portugal 16 705 0.6× 224 0.9× 104 0.6× 149 1.0× 166 1.2× 76 1.1k
Fernando Friões Portugal 15 1.0k 0.9× 224 0.9× 65 0.3× 193 1.3× 73 0.5× 45 1.3k
Serdar Farhan Austria 20 612 0.5× 113 0.5× 71 0.4× 380 2.5× 79 0.6× 69 1.1k
Ahmet Temizhan Türkiye 20 690 0.6× 139 0.6× 54 0.3× 210 1.4× 184 1.3× 92 1.3k
Omar F. AbouEzzeddine United States 24 1.4k 1.3× 540 2.2× 122 0.7× 326 2.2× 174 1.3× 61 2.0k
András Komócsi Hungary 21 1.3k 1.1× 339 1.4× 80 0.4× 571 3.8× 35 0.3× 94 1.8k
Grzegorz Kopeć Poland 22 866 0.8× 875 3.6× 76 0.4× 200 1.3× 56 0.4× 182 1.7k
Lucia Barbieri Italy 23 880 0.8× 144 0.6× 53 0.3× 502 3.3× 56 0.4× 114 1.6k

Countries citing papers authored by David Sim

Since Specialization
Citations

This map shows the geographic impact of David Sim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Sim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Sim more than expected).

Fields of papers citing papers by David Sim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Sim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Sim. The network helps show where David Sim may publish in the future.

Co-authorship network of co-authors of David Sim

This figure shows the co-authorship network connecting the top 25 collaborators of David Sim. A scholar is included among the top collaborators of David Sim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Sim. David Sim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rhee, Chin Kook, Fanny W.S. Ko, Giap Van Vu, et al.. (2025). Management of COPD With Cardiovascular Risk in Asia: A Review by the Asian Pacific Society of Respirology COPD Assembly. Respirology. 30(9). 817–830. 2 indexed citations
2.
Jin, Xuanyi, Wan Ting Tay, Dinna Soon, et al.. (2025). Patients with chronic heart failure and predominant left atrial versus left ventricular myopathy. Cardiovascular Ultrasound. 23(1). 1–1. 1 indexed citations
3.
Mann, Douglas L., Johny Nicolas, Brian Claggett, et al.. (2024). Angiotensin Receptor-Neprilysin Inhibition in Patients With STEMI vs NSTEMI. Journal of the American College of Cardiology. 83(9). 904–914. 6 indexed citations
4.
Tromp, Jasper, et al.. (2023). Examining predictors for 6-month mortality and healthcare utilization for patients admitted for heart failure in the acute care setting. International Journal of Cardiology. 390. 131237–131237. 1 indexed citations
5.
Finkelstein, Eric, et al.. (2023). Weak Grip Strength Predicts Higher Unplanned Healthcare Utilization Among Patients with Heart Failure. ESC Heart Failure. 11(1). 306–314. 5 indexed citations
6.
7.
Ouwerkerk, Wouter, Jasper Tromp, Xuanyi Jin, et al.. (2020). Heart Failure with Preserved Ejection Fraction Diagnostic Scores in an Asian Population. European Journal of Heart Failure. 22(9). 1737–1739. 11 indexed citations
8.
Yap, Jonathan, John Carson Allen, Fazlur Jaufeerally, et al.. (2019). Prediction of Survival in Asian Patients Hospitalized With Heart Failure: Validation of the OPTIMIZE-HF Risk Score. Journal of Cardiac Failure. 25(7). 571–575. 14 indexed citations
9.
Tan, Eugene S.J., Siew Pang Chan, Chang Xu, et al.. (2019). Cornell product is an ECG marker of heart failure with preserved ejection fraction. Heart Asia. 11(1). e011108–e011108. 9 indexed citations
10.
Malhotra, Chetna, Ratna Singh, Semra Özdemir, et al.. (2018). Study protocol for a cohort study of patients with advanced heart failure in Singapore. BMJ Open. 8(9). e022248–e022248. 11 indexed citations
11.
Go, Yun Yun, John Carson Allen, Anders Sahlén, et al.. (2018). Defining a ‘Frequent Admitter’ Phenotype Among Patients with Repeat Heart Failure Admissions. European Journal of Heart Failure. 21(3). 311–318. 10 indexed citations
12.
Gohar, Aisha, Jenny Chong, Oi Wah Liew, et al.. (2017). The Prognostic Value of Highly Sensitive Cardiac Troponin Assays for Adverse Events in Men and Women with Stable Heart Failure and a Preserved vs. Reduced Ejection Fraction. European Journal of Heart Failure. 19(12). 1638–1647. 64 indexed citations
13.
Bosch, Lena, Carolyn S.P. Lam, Lingli Gong, et al.. (2017). Right Ventricular Dysfunction in Left-Sided Heart Failure with Preserved Versus Reduced Ejection Fraction. European Journal of Heart Failure. 19(12). 1664–1671. 227 indexed citations
14.
Cowie, Martín, Yu. M. Lopatin, Clara Saldarriaga, et al.. (2017). The Optimize Heart Failure Care Program: Initial lessons from global implementation. International Journal of Cardiology. 236. 340–344. 24 indexed citations
15.
Yap, Jonathan, David Sim, Choon Pin Lim, et al.. (2015). Predictors of two-year mortality in Asian patients with heart failure and preserved ejection fraction. International Journal of Cardiology. 183. 33–38. 27 indexed citations
16.
Chan, Michelle, Rajalakshmi Santhanakrishnan, Jenny Chong, et al.. (2015). Growth Differentiation Factor 15 in Heart Failure with Preserved vs. Reduced Ejection Fraction. European Journal of Heart Failure. 18(1). 81–88. 134 indexed citations
17.
Yeo, Tee Joo, Poh Shuan Daniel Yeo, Raymond Wong, et al.. (2014). Iron Deficiency in a Multi-Ethnic Asian Population with and Without Heart Failure: Prevalence, Clinical Correlates, Functional Significance and Prognosis. European Journal of Heart Failure. 16(10). 1125–1132. 104 indexed citations
18.
19.
Santhanakrishnan, Rajalakshmi, Jenny Chong, Tze Pin Ng, et al.. (2012). Growth Differentiation Factor 15, ST2, High-Sensitivity Troponin T, and N-Terminal Pro Brain Natriuretic Peptide in Heart Failure with Preserved vs. Reduced Ejection Fraction. European Journal of Heart Failure. 14(12). 1338–1347. 156 indexed citations
20.
Kalimuddin, Shirin, October M. Sessions, Yanan Hou, et al.. (2012). Successful clearance of human parainfluenza virus type 2 viraemia with intravenous ribavirin and immunoglobulin in a patient with acute myocarditis. Journal of Clinical Virology. 56(1). 37–40. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Fazlur Jaufeerally Breakdown of academic impact, for papers by Patrícia Lourenço Breakdown of academic impact, for papers by Fernando Friões Breakdown of academic impact, for papers by Serdar Farhan Breakdown of academic impact, for papers by Ahmet Temizhan Breakdown of academic impact, for papers by Omar F. AbouEzzeddine Breakdown of academic impact, for papers by András Komócsi Breakdown of academic impact, for papers by Grzegorz Kopeć Breakdown of academic impact, for papers by Lucia Barbieri
Rankless by CCL
2026